Prostaglandin F2-alpha (PGF2α) in Vitiligo | NCT03755830 | Trialant

Prostaglandin F2-alpha (PGF2α) in Vitiligo | NCT03755830 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
vitiligo patients	Active Comparator	Two skin biopsies (lesional and non-lesional) will be taken from every patient.	Other: Skin biopsy
healthy controls	Experimental	A skin biopsy will be taken from each control subject.	Other: Skin biopsy

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Skin biopsy	Other	Two skin biopsies (lesional and non-lesional) will be taken from every patient. Also a skin biopsy will be taken from each control subject.	healthy controls

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Measurement of tissue levels of PGF2α in vitiligo patients and compare them with healthy controls.	Measurement of tissue levels of PGF2α in vitiligo patients and compare them with healthy controls to study and verify the hypothesis of involvement of PGF2α in the pathogenesis of vitiligo.• Skin biopsy for assessment of tissue levels of the PGF2α will be taken from both lesional and non lesional skin of patients of vitiligo and from normal skin of healthy controls. All skin biopsies are from non-sun exposed sites.	6 months

Condition Browse Module